Diabetes atherosclerosis intervention study (DAIS): Quantitative coronary angiographic analysis of coronary artery atherosclerosis

Catheterization and Cardiovascular Diagnosis

Volumn 44, Issue 3, 1998, Pages 249-256

  McLaughlin, Peter R ^a   Gladstone, Peter ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Coronary angiography; Diabetes; Fenofibrate; Intervention trial; Q; Quantitative coronary analysis; Regression of coronary artery atheroeclerosis

Indexed keywords

FENOFIBRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SURGERY; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTILIPEMIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; OBSERVER VARIATION; PROCETOFEN; REPRODUCIBILITY OF RESULTS;

EID: 0031804375     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199807)44:3<249::AID-CCD1>3.0.CO;2-5     Document Type: Article

References (28)

1. Steiner G: The Diabetes Atherosclerosis Intervention Study (DAIS): A study conducted in cooperation with the World Health Organization. Diabetologia 39:1655-1661, 1996.
2. Entmacher PS, Krall LP, Kranczer SN: "Diabetes Mortality From Vital Statistics in Joslin's Diabetes Mellitus." Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds). Philadelphia, PA: Lea & Febiger. 1985, pp 278-297.
3. Steiner G: Diabetes and atherosclerosis: An overview. Diabetes 30: I-7, 1981.
4. Garcia ML, McNamara PM, Gordon TL, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow-up study. Diabetes 23:105-111, 1974.
5. Kleinman JC: National health and nutrition examination. American J Epidemiol 128:389, 1988.
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993.
7. Hirata Y, Mihara T: Princicipal causes of death among Japanese from 1968 to 1970. In Baba S, Gotot Y, Fukui I (eds): "Diabetes Mellitus in Asia." Amsterdam: Excerpta Medica, 1976, pp 91-97.
8. Fontbonne A, Eschwege E, Cambien F: Hypertriglyceridemia as a risk factor of coronary heart disease mortality in patients with impaired glucose tolerance or diabetes: Results from the 11 year follow-up of the Paris prospective study. Diabetologia 332:300-304, 1989.
9. Zhao XQ, Brown BG, Hillger L: Effects of intensive lipid lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B. Circulation 88:2744-2753, 1993.
10. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. New Engl J Med 323:1289-1298, 1990.
11. Campos CT, Nguyen P, Buchwald and the POSCH Group: Effect of cholesterol lowering on PTCA, CABG and heart transplantation rates: POSCH long-term follow-up study. Circulation 88:386, 1993.
12. Blankenhorn DH, Nessim SA, Hohnson RL, Sanmarco ME, Axen SP, Cashin-Hemphill L: Beneficial effects of combined colestipolniacin therapy on coronary atherosclerosis and coronary atherosclerosis and coronary venous bypass grafts. JAMA 257:3233-3240, 1987.
13. Cashin-Hemphill L, Mack W, AlBree L: Coronary progression predicts future cardiac events. Circulation 88:363, 1993.
14. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerois Regression Study (STARS). Lancet 339:563-569, 1992.
15. Haskell WL, Alderman EL, Fair JM: Beneficial angiographic and clinical response to multifactor modification in the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 89:975-990, 1994.
16. Byington RP, Jukema W, Salonen JT: Reduction in cardiovascular events during pravastatin therapy. Circulation 92:2419-2425, 1995.
17. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994.
18. Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire J: Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347:849-853, 1996.
19. MAAS Investigators: Effects of simvastatin on coronary atheroma: The multicentre anti-atheroma study (MAAS). Lancet 344:633-638, 1994.
20. Arntzenius AC, Kromhout D, Barth JD, Reiber JH, Bruschke AV, Buis B: Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. New Engl J Med 312:805-811, 1985.
21. Schuler G, hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J: Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 86:1-11, 1992.
22. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 264:3007-3012, 1990.
23. Austen WG, Edwards JE, Frye RL: A reporting system on patients evaluated for coronary artery disease. Circulation 51:5-40, 1975.
24. Reiber JHC, Serruys PW: "Quantitative Coronary Angiography. Developments in Cardiovascular Medicine." Dordrecht: Kluwer Academic Publishers, 1991.
25. Ellis S, Sanders MS, Goulet C, Miller R, Cain KC, Lesperance J, Bourassa MG, Alderman EL: Optimal detection of progression of coronary artery disease: Comparison of methods suitable for risk factor intervention trials. Circulation 74:1235-1242, 1986.
26. Foley DP, Escaned J, Strauss BH, di Mario C, Haase J, Keane D, Hermans WRM, Rensing BJ, de Feyter PJ, Serruys PW: Quantitative coronary angiography in interventional cardiology: Clinical application of QCA measurements. Progr Cardiovasc Dis 36:363-384, 1974.
27. de Feyter PJ, Serruys PW, Davies MJ, Richardson P, Lubsen J, Oliver MF: Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Circulation 84:412-423, 1991.
28. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB: Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Annals Intern Med 121:348-354, 1994.